95 related articles for article (PubMed ID: 17152498)
1. [Docetaxel in the treatment of advanced breast cancer ].
Wang ZP; Sun Y; Zhang XR; Zhang MH; Wang XW; Yu XJ; Nan KJ; Li EX; Liu JW; Gao YJ; Guan XQ; Song SP; Sheng LJ; Wang DL; Wang ZX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):468-70. PubMed ID: 17152498
[TBL] [Abstract][Full Text] [Related]
2. [A randomized phase II trial of docetaxel and doxorubicin in treatment for patients with non-small-cell lung cancer who have failed previous platinum-based chemotherapy].
Wang ZP; Sun Y; Zhang XR; Zhang MH; Wang XW; Yu XJ; Nan KJ; Li EX; Liu JW; Gao YJ; Guan XQ; Song SP; Sheng LJ; Wang DL; Wang ZX
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):465-8. PubMed ID: 19024525
[TBL] [Abstract][Full Text] [Related]
3. [Phase I/II clinical trial of weekly administration of docetaxel plus cisplatin for advanced non-small cell lung cancer].
Li JL; Zhang XR; Liu JW; Chen ZY; Lin YC; Wang YD; Chen Q; Nan KJ; Song SP; Han FC; Zhu YZ; Li LY; Zheng YH; Chu DT
Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):309-12. PubMed ID: 16875636
[TBL] [Abstract][Full Text] [Related]
4. [Phase II study of docetaxel plus epirubicin versus docetaxel plus cisplatin as first-line chemotherapy for advanced breast cancer].
Wang YJ; Wu Q; Su FX; Zhou LZ; Ye ZB; Yang JQ; Ren H; Zhang J; Ding G; Fu Q; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):541-4. PubMed ID: 19062725
[TBL] [Abstract][Full Text] [Related]
5. Dose-escalation study of docetaxel in combination with mitoxantrone as first-line treatment in patients with metastatic breast cancer.
Kouroussis C; Androulakis N; Kakolyris S; Souglakos J; Kotsakis T; Mavroudis D; Katsogridakis K; Vardakis N; Hatzidaki D; Samonis G; Vlachonikolis J; Georgoulias V
J Clin Oncol; 1999 Mar; 17(3):862-9. PubMed ID: 10071277
[TBL] [Abstract][Full Text] [Related]
6. [Randomized controlled trial of two kinds of home-produced docetaxel in China for advanced breast cancer].
Liu DG; Peng RJ; Feng FY; Hu XH; Tang GD; Xiong JP; Zhao HY; Guo Y; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1557-60. PubMed ID: 17166386
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and safety of docetaxel for elderly advanced breast cancer patients].
Tashiro H; Mashino K; Shibahara K; Endo K; Fujii K; Ninomiya M; Ikeda T; Sakata H
Gan To Kagaku Ryoho; 2007 Mar; 34(3):453-5. PubMed ID: 17353642
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel-ifosfamide combination in patients with HER2-non-overexpressing advanced breast cancer failing prior anthracyclines.
Kosmas C; Tsavaris N; Malamos N; Tsakonas G; Gassiamis A; Polyzos A; Mylonakis N; Karabelis A
Invest New Drugs; 2007 Oct; 25(5):463-70. PubMed ID: 17370037
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer.
Kaya AO; Coskun U; Buyukberber S; Benekli M; Tekin E; Cifter C; Ozturk B; Yildiz R; Yaman E; Uner A; Yamac D
J BUON; 2010; 15(2):248-54. PubMed ID: 20658717
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.
Smith RE; Anderson SJ; Brown A; Scholnik AP; Desai AM; Kardinal CG; Lembersky BC; Mamounas EP
Clin Breast Cancer; 2002 Dec; 3(5):333-40. PubMed ID: 12533263
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor.
Kornek GV; Ulrich-Pur H; Penz M; Haider K; Kwasny W; Depisch D; Kovats E; Lang F; Schneeweiss B; Scheithauer W
J Clin Oncol; 2001 Feb; 19(3):621-7. PubMed ID: 11157011
[TBL] [Abstract][Full Text] [Related]
12. Improvement of safety profile of docetaxel by weekly administration in patients with metastatic breast cancer.
Warm M; Nawroth F; Ohlinger R; Valter M; Pantke E; Mallmann P; Harbeck N; Kates R; Thomas A
Onkologie; 2007 Sep; 30(8-9):436-41. PubMed ID: 17848815
[TBL] [Abstract][Full Text] [Related]
13. A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer.
Ford HE; Yap YS; Miles DW; Makris A; Hall M; Miller L; Harries M; Smith IE; Johnston SR
Cancer Chemother Pharmacol; 2006 Dec; 58(6):809-15. PubMed ID: 16528527
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
Chevallier B; Fumoleau P; Kerbrat P; Dieras V; Roche H; Krakowski I; Azli N; Bayssas M; Lentz MA; Van Glabbeke M
J Clin Oncol; 1995 Feb; 13(2):314-22. PubMed ID: 7844592
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer.
Aihara T; Takatsuka Y; Itoh K; Sasaki Y; Katsumata N; Watanabe T; Noguchi S; Horikoshi N; Tabei T; Sonoo H; Hiraki S; Inaji H
Oncology; 2003; 64(2):124-30. PubMed ID: 12566909
[TBL] [Abstract][Full Text] [Related]
16. [Low dose-intensity docetaxel monotherapy for patients with anthracycline-resistant metastatic breast cancer in poor physical status].
Liu ZF; Zhang XQ; Guo QS; Yang XG; Song SP; Wu N; Wang MY
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):317-9. PubMed ID: 18788642
[TBL] [Abstract][Full Text] [Related]
17. Weekly docetaxel/paclitaxel in pretreated metastatic breast cancer.
Gennari A; Guarneri V; Landucci E; Orlandini C; Rondini M; Salvadori B; Ricci S; Conte PF
Clin Breast Cancer; 2002 Dec; 3(5):346-52. PubMed ID: 12533265
[TBL] [Abstract][Full Text] [Related]
18. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
19. [Docetaxel combined with cisplatin in the treatment of anthracycline-resistant advanced breast cancer].
Xu BH; Zhao LM; Wang JY; Yuan P
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):471-3. PubMed ID: 17152499
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel in combination chemotherapy for metastatic breast cancer.
Khayat D; Antoine E
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
